Key Drivers
- Stable profitability
- Declining liquidity
- Elevated leverage
AIAI Summary
HTB is now an execution-driven regional-bank investment: solid 11% ROE and healthcare growth potential support the franchise, but upside from ~$47 depends on Blue Ridge delivering accretive synergies without worsening deposit attrition, liquidity, or margin pressure—making deal economics and post-close deposit retention the key catalysts to monitor.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Stable profitability
- •Declining liquidity
- •Elevated leverage
HTB remains profitable with solid capital growth and dividend coverage, but weakening liquidity, low quarterly cash flow, high leverage, and a less-attractive valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Defended support
- •Capped rallies
- •Neutral momentum
HTB was range-bound last month, with $46.40–$46.70 support holding but upside capped near $48.30–$48.80; watch for a breakout above $48.80 or breakdown below $46.40.
Brief spike to $48.76 followed by a retreat to $47.08
Sentiment & News
Key News Insights:
- •New institutional stake
- •73,110 shares
- •SEC filing
Bank of New York Mellon disclosed a new $3.65M stake in HomeTrust Bancshares, signaling institutional interest.
The disclosure is modestly positive for HTB sentiment, though its fundamental impact remains limited
Similar Companies in Financial Services
Other companies in the same sector with AI ratings